SLC6A12

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, SLC6A12 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated SLC6A12 data layer compared with 4 for mutation status and 1 for mass-spec protein.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher SLC6A12 RNA is associated with better overall survival. In most high-consensus cancer types, elevated SLC6A12 expression acts as an unfavorable survival marker, although some lineages such as KIRP and BLCA show a favorable association.

KIRP, UCEC, and BLCA are the cancer types where SLC6A12 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KIRPOSQuartileAll0.9660.776<.001107view →
UCECOSTertileII,III,IV0.7840.930<.00170view →
BLCAOSTertileAll0.7780.418<.00148view →
OVOSTertileII,III,IV0.7980.896.00638view →
HNSCDFSTertileIII,IV0.4020.260.00236view →
LIHCOSMedianIII,IV0.7610.472.00724view →
SKCMDFSQuartileII,III,IV0.3140.165.00320view →
LUSCDFSMedianII,III,IV0.6110.858.00618view →
LAMLDFSTertileAll0.3900.714.00716view →
KIRCDFSQuartileIV0.7500.360.01313view →
LUADDFSMedianIV0.3010.753.00612view →
UVMDFSMedianII,III,IV0.4150.782.01312view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

SLC6A12–KIRP (OS)

Kaplan–Meier survival curve for SLC6A12 RNA-high vs -low samples in KIRP.

Open the KIRP breakdown →

Exploration